Shirakawa; Kamon
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shirakawa; Kamon.The latest application filed is for "novel anti-presepsin antibody".
Company Profile
0.26.28
- Shirakawa; Kamon - Yokohama JP
- Shirakawa; Kamon - Tokyo N/A JP
- SHIRAKAWA; Kamon - Yokohama-shi Kanagawa
- Shirakawa; Kamon - Shinjuku-ku JP
- Shirakawa; Kamon - Shizuoka JP
- Shirakawa; Kamon - Saitama JP
Patent Activity
| Patent | Date |
|---|---|
| Specifically purified anti-presepsin antibody Grant 11,117,974 - Shirakawa September 14, 2 | 2021-09-14 |
| Specifically purified anti-presepsin antibody Grant 11,084,883 - Shirakawa August 10, 2 | 2021-08-10 |
| Method for prediction of prognosis of sepsis Grant 11,041,864 - Matsuya , et al. June 22, 2 | 2021-06-22 |
| Novel Anti-presepsin Antibody App 20210107990 - Shirakawa; Kamon | 2021-04-15 |
| Anti-presepsin antibody Grant 10,676,532 - Shirakawa | 2020-06-09 |
| Specifically Purified Anti-presepsin Antibody App 20180237537 - SHIRAKAWA; Kamon | 2018-08-23 |
| Diagnosis of respiratory tract infectious disease using urine specimens Grant 10,054,585 - Shirakawa August 21, 2 | 2018-08-21 |
| Novel Anti-presepsin Antibody App 20180201688 - SHIRAKAWA; Kamon | 2018-07-19 |
| Diagnosis of respiratory tract infectious disease using blood specimens Grant 10,024,869 - Shirakawa July 17, 2 | 2018-07-17 |
| Anti-presepsin antibody Grant 9,951,142 - Shirakawa April 24, 2 | 2018-04-24 |
| Diagnosis Of Respiratory Tract Infectious Disease Using Urine Specimens App 20160169889 - Shirakawa; Kamon | 2016-06-16 |
| Diagnosis Of Respiratory Tract Infectious Disease Using Blood Specimens App 20160161506 - Shirakawa; Kamon | 2016-06-09 |
| Diagnosis of respiratory tract infectious diseases using urine specimens Grant 9,297,802 - Shirakawa March 29, 2 | 2016-03-29 |
| Diagnosis of respiratory tract infectious disease using blood specimens Grant 9,291,631 - Shirakawa March 22, 2 | 2016-03-22 |
| Novel Anti-presepsin Antibody App 20150239982 - SHIRAKAWA; Kamon | 2015-08-27 |
| Diagnosis Of Respiratory Tract Infectious Disease Using Blood Specimens App 20140213507 - Shirakawa; Kamon | 2014-07-31 |
| Diagnosis Of Respiratory Tract Infectious Diseases Using Urine Specimens App 20140171359 - Shirakawa; Kamon | 2014-06-19 |
| Anti-platelet Membrane Glycoprotein Vi Monoclonal Antibody App 20140044723 - Takayama; Hiroshi ; et al. | 2014-02-13 |
| Method For Selecting Patient To Be Given Drug For Treating Septicemia App 20130280252 - Imai; Mariko ; et al. | 2013-10-24 |
| Anti-platelet membrane glycoprotein VI monoclonal antibody Grant 8,524,870 - Takayama , et al. September 3, 2 | 2013-09-03 |
| Anti-platelet Membrane Glycoprotein Vi Monoclonal Antibody App 20130095120 - Takayama; Hiroshi ; et al. | 2013-04-18 |
| Anti-platelet membrane glycoprotein VI monoclonal antibody Grant 8,389,692 - Takayama , et al. March 5, 2 | 2013-03-05 |
| Soluble CD14 antigen Grant 8,124,722 - Furusako , et al. February 28, 2 | 2012-02-28 |
| Anti-platelet Membrane Glycoprotein Vi Monoclonal Antibody App 20110217318 - TAKAYAMA; HIROSHI ; et al. | 2011-09-08 |
| Anti-platelet membrane glycoprotein VI monoclonal antibody Grant 7,977,461 - Takayama , et al. July 12, 2 | 2011-07-12 |
| Assay kit and antibody for human low molecular weight CD14 Grant 7,901,900 - Furusako , et al. March 8, 2 | 2011-03-08 |
| Soluble CD14 antigen Grant 7,608,684 - Furusako , et al. October 27, 2 | 2009-10-27 |
| Meltrins Grant 7,605,226 - Fujisawa , et al. October 20, 2 | 2009-10-20 |
| Novel Soluble Cd14 Antigen App 20090203052 - FURUSAKO; Shoji ; et al. | 2009-08-13 |
| Anti-platelet Membrane Glycoprotein Vi Monoclonal Antibody App 20090092612 - Takayama; Hiroshi ; et al. | 2009-04-09 |
| Anti-platelet Membrane Glycoprotein Vi Monoclonal Antibody App 20090041783 - Takayama; Hiroshi ; et al. | 2009-02-12 |
| Assay kit and antibody for human low molecular weight CD14 App 20090029396 - Furusako; Shoji ; et al. | 2009-01-29 |
| Methods for detecting human low molecular weight CD14 Grant 7,465,547 - Furusako , et al. December 16, 2 | 2008-12-16 |
| Pharmaceutical Composition Containing Meltrin Antagonist App 20080292619 - Sehara; Atsuko ; et al. | 2008-11-27 |
| Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding Grant 7,264,967 - Furusako , et al. September 4, 2 | 2007-09-04 |
| Monoclonal antibody against platelet membrane glycoprotein VI App 20070025992 - Takayama; Hiroshi ; et al. | 2007-02-01 |
| Meltrins App 20060247164 - Fujisawa; Atsuko ; et al. | 2006-11-02 |
| Meltrins Grant 7,060,791 - Fujisawa , et al. June 13, 2 | 2006-06-13 |
| Novel soluble CD14 antigen App 20060068445 - Furusako; Shoji ; et al. | 2006-03-30 |
| Anti-il13 receptor alpha1 neutralizing antibody App 20050154192 - Shirakawa, Kamon ; et al. | 2005-07-14 |
| Method for the measurement of soluble CD14 proteins separately Grant 6,916,628 - Furusako , et al. July 12, 2 | 2005-07-12 |
| Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding App 20040091478 - Furusako, Shoji ; et al. | 2004-05-13 |
| Tlr/cd14 binding inhibitor App 20040092712 - Furusako, Shoji ; et al. | 2004-05-13 |
| Novel cell adhesion molecule specific to activated leukocyte App 20040076992 - Nakamura, Yusuke ; et al. | 2004-04-22 |
| Meltrins App 20020147132 - Fujisawa, Atsuko ; et al. | 2002-10-10 |
| Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody Grant 6,114,507 - Shirakawa , et al. September 5, 2 | 2000-09-05 |
| Method for measuring adenyl group-containing substances using heteropoly-acid Grant 5,610,016 - Sato , et al. March 11, 1 | 1997-03-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 